Cite
HARVARD Citation
Armenian, S. et al. (2016). Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure. BMC cardiovascular disorders. 16 (1), pp. 1-11. [Online].